S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17

Altus Strategies (ALS) Share Forecast, Price & News

GBX 53
-0.50 (-0.93%)
(As of 05/17/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
45,657 shs
Average Volume
38,060 shs
Market Capitalization
£62.18 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive ALS News and Ratings via Email

Sign-up to receive the latest news and ratings for Altus Strategies and its competitors with MarketBeat's FREE daily newsletter.

Altus Strategies logo

About Altus Strategies

Altus Strategies plc, together its subsidiaries, discovers, acquires, explores for, and develops mineral properties in Africa. The company primarily explores for gold, bauxite, copper, iron ore, zinc, lead, silver, tin, and tungsten deposits. It has a portfolio of projects, including Korali Sud (Diba) gold project and Lakanfla gold project located in Western Mali; Tabakorole gold project and Pitiangoma Est gold project located in Southern Mali; Wadi Jundi gold project, Bakriyah gold project, Abu Diwan gold project, Wadi Dubur gold project located in Egypt; Laboum gold project located in Northern Cameroon; Bikoula iron ore project located in Southern Cameroon; Agdz copper-silver project, Takzim copper-zinc project, Zaer copper project, and Ammas zinc-lead project located in Central Morocco; Igzougza copper-silver project, Azrar copper project, and Tata copper project located in Western Morocco; Daro copper-gold project and Zager copper-gold project located in Northern Ethiopia; and Leopard Rock gold prospect located in Western Liberia. Altus Strategies plc was incorporated in 2007 and is based in Didcot, the United Kingdom.


Altus Strategies granted mining licence at Korali Sud in Mali
Altus executes transaction on Toura nickel property
Aktuelle Empfehlungen zur ALTUS STRATEGIES Aktie
See More Headlines

Industry, Sector and Symbol

Industrial Metals & Minerals
Year Founded

Sales & Book Value

Annual Sales
£157.95 thousand
Cash Flow
GBX 8.22 per share
Book Value
GBX 17.60 per share


Pretax Margin




Free Float
Market Cap
£62.18 million
Not Optionable


Overall MarketRank

1.16 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Altus Strategies (LON:ALS) Frequently Asked Questions

Who are Altus Strategies' key executives?
Altus Strategies' management team includes the following people:
  • Mr. Steven James Poulton BSC, MSc, MCSM, CEO & Exec. Director (Age 45, Pay $200k)
  • Mr. Martin John Keylock, Chief Financial Officer
  • Mr. Matthew Roy Grainger, Exec. Director (Age 49, Pay $160k)
  • Mr. William Slater, VP of Operations
  • Mr. Alister Hume, Chief Investment Officer
  • Ms. Sandra Naomi Bates, Gen. Counsel (Age 49)
  • Mr. Michael Starke, VP of Corp. Devel.
  • Mr. David Lindsay Miles B.Sc., C.A., C.P.A., BSc. Geology, Adviser (Age 71)
  • Ms. Amilha Pio Young, Company Sec. & Legal Counsel of UK (Age 59)
  • Ms. Val Mitchell, Office & Fin. Mang.
What other stocks do shareholders of Altus Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Altus Strategies investors own include NewAge (NBEV), Johnson Controls International (JCI), Hurricane Energy (HRCXF), EyeGate Pharmaceuticals (EYEG), Bank of America (BAC) and Adient (ADNT).

What is Altus Strategies' stock symbol?

Altus Strategies trades on the London Stock Exchange (LON) under the ticker symbol "ALS."

How do I buy shares of Altus Strategies?

Shares of ALS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Altus Strategies' stock price today?

One share of ALS stock can currently be purchased for approximately GBX 53.

How much money does Altus Strategies make?

Altus Strategies has a market capitalization of £62.18 million and generates £157.95 thousand in revenue each year.

How many employees does Altus Strategies have?

Altus Strategies employs 30 workers across the globe.

What is Altus Strategies' official website?

The official website for Altus Strategies is www.altus-strategies.com.

How can I contact Altus Strategies?

Altus Strategies' mailing address is 14 Station Road, The Orchard Centre, DIDCOT, OX11 7LL, United Kingdom. The company can be reached via phone at +44-1235-511767.

This page was last updated on 5/18/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.